Metformin ameliorates cardiopulmonary toxicity induced by chlorpyrifos

Ramtin Farhadi1,2, Marzieh Daniali1,2, Maryam Baeeri1,2

  • 1Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS), Tehran, Iran.

PubMed

Insights

Metformin protects against chlorpyrifos (CPF) pesticide-induced heart and lung damage by reducing oxidative stress and inflammation. This study shows metformin

Area of Science:

  • Toxicology and Pharmacology
  • Cardiovascular and Respiratory Research

Background:

  • Chlorpyrifos (CPF) is a widely used organophosphate pesticide with known organ-damaging effects.
  • Metformin exhibits protective properties against cellular dysfunction induced by oxidative stress and inflammation.

Purpose of the Study:

  • To investigate the protective effects of metformin on chlorpyrifos-induced damage in the heart and lungs.
  • To elucidate the mechanisms underlying metformin's modulatory impact on CPF toxicity.

Main Methods:

  • Wistar rats were treated with varying doses of metformin and CPF.
  • Analysis included oxidative stress biomarkers (ROS, MDA), inflammatory cytokines (TNF-α), HMGB1 gene expression, DNA damage, lactate levels, ADP/ATP ratio, gene expression (TRADD, TERT, KL), and histological examination of heart and lung tissues.

Main Results:

  • Metformin significantly mitigated CPF-induced impairments in heart and lung tissues.
  • The protective effects involved modulation of oxidative stress, inflammation, and DNA damage markers.

Conclusions:

  • Metformin demonstrates significant protective potential against chlorpyrifos-induced cardiorespiratory toxicity.
  • Metformin may serve as a therapeutic agent to counteract pesticide-induced organ damage.

Related Concept Videos

Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
234
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
270
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
626
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
199
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
422
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
401